The Role of ARID1A in the Nonestrogenic Modulation of IGF-1 Signaling

Sham Jdeed1, Edina Erdős2, Bálint L Bálint2

  • 1Department of Clinical Oncology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Insights

Repurposed drugs bexarotene and carvedilol suppress breast cancer growth by altering ARID1A protein levels and regulating insulin-like growth factor signaling pathways. This offers a new therapeutic strategy for breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • ARID1A is a tumor suppressor protein involved in cancer gene expression.
  • Retinoid X receptor ligands affect breast cell proliferation and differentiation.
  • Targeting ARID1A pharmacologically remains a challenge.

Purpose of the Study:

  • To investigate the effect of bexarotene (Bex) and carvedilol (Carv) on ARID1A levels and breast cancer cell proliferation.
  • To elucidate the mechanism by which Bex + Carv impacts gene expression, particularly related to insulin-like growth factor (IGF) signaling.
  • To explore the therapeutic potential of modulating ARID1A activity in breast cancer.

Main Methods:

  • Cell proliferation assays using MCF10DCIS.com and MCF-7 breast cancer cell lines.
  • Western blotting to assess ARID1A protein levels.
  • Chromatin immunoprecipitation sequencing (ChIP-seq) to analyze genomic distribution of ARID1A and H3K27ac.
  • Gene knockdown experiments for ARID1A.
  • In vitro assays using IGF-1 receptor neutralizing antibody.

Main Results:

  • Low-dose Bex combined with Carv suppressed proliferation and reduced ARID1A levels in breast cancer cells.
  • Bex + Carv altered the genomic distribution of ARID1A and H3K27ac at IGF signaling-related sites, suppressing IGF-1 receptor (IGF-1R) and IRS1.
  • ARID1A knockdown increased IGF-1R levels and abrogated the suppressive effects of Bex + Carv, while stimulating proliferation.
  • Elevated IGF-1R or IRS1 expression correlated with poor survival in ER-negative breast cancer patients.

Conclusions:

  • ARID1A redistribution directly impacts the expression and growth regulation of IGF-1-related genes.
  • Repurposed drugs Bex and Carv can induce ARID1A redistribution under nonestrogenic conditions.
  • Pharmacologic modulation of ARID1A offers a potential strategy to downregulate protumorigenic IGF-1 activity in breast cancer.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.4K
Cell Signaling in Plants01:25

Cell Signaling in Plants

Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
5.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K